185 related articles for article (PubMed ID: 30097865)
21. ADP-ribosylation: new facets of an ancient modification.
Palazzo L; Mikoč A; Ahel I
FEBS J; 2017 Sep; 284(18):2932-2946. PubMed ID: 28383827
[TBL] [Abstract][Full Text] [Related]
22. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.
Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH
Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462
[TBL] [Abstract][Full Text] [Related]
23. ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives.
Manco G; Lacerra G; Porzio E; Catara G
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327636
[TBL] [Abstract][Full Text] [Related]
24. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
[TBL] [Abstract][Full Text] [Related]
25. Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.
Perina D; Mikoč A; Ahel J; Ćetković H; Žaja R; Ahel I
DNA Repair (Amst); 2014 Nov; 23():4-16. PubMed ID: 24865146
[TBL] [Abstract][Full Text] [Related]
26. Biallelic
Beijer D; Agnew T; Rack JGM; Prokhorova E; Deconinck T; Ceulemans B; Peric S; Milic Rasic V; De Jonghe P; Ahel I; Baets J
Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34479984
[TBL] [Abstract][Full Text] [Related]
27. ADP-ribosyltransferases, an update on function and nomenclature.
Lüscher B; Ahel I; Altmeyer M; Ashworth A; Bai P; Chang P; Cohen M; Corda D; Dantzer F; Daugherty MD; Dawson TM; Dawson VL; Deindl S; Fehr AR; Feijs KLH; Filippov DV; Gagné JP; Grimaldi G; Guettler S; Hoch NC; Hottiger MO; Korn P; Kraus WL; Ladurner A; Lehtiö L; Leung AKL; Lord CJ; Mangerich A; Matic I; Matthews J; Moldovan GL; Moss J; Natoli G; Nielsen ML; Niepel M; Nolte F; Pascal J; Paschal BM; Pawłowski K; Poirier GG; Smith S; Timinszky G; Wang ZQ; Yélamos J; Yu X; Zaja R; Ziegler M
FEBS J; 2022 Dec; 289(23):7399-7410. PubMed ID: 34323016
[TBL] [Abstract][Full Text] [Related]
28. ADP-ribosylation: An emerging direction for disease treatment.
Liu YT; Che Y; Qiu HL; Xia HX; Feng YZ; Deng JY; Yuan Y; Tang QZ
Ageing Res Rev; 2024 Feb; 94():102176. PubMed ID: 38141734
[TBL] [Abstract][Full Text] [Related]
29. A role of intracellular mono-ADP-ribosylation in cancer biology.
Scarpa ES; Fabrizio G; Di Girolamo M
FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
[TBL] [Abstract][Full Text] [Related]
30. The Promise of Proteomics for the Study of ADP-Ribosylation.
Daniels CM; Ong SE; Leung AK
Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
[TBL] [Abstract][Full Text] [Related]
31. Poly (ADP-ribose) polymerase1 regulates growth and multicellularity in D. discoideum.
Jubin T; Kadam A; Saran S; Begum R
Differentiation; 2016; 92(1-2):10-23. PubMed ID: 27021638
[TBL] [Abstract][Full Text] [Related]
32. When PARPs Meet Antiviral Innate Immunity.
Zhu H; Zheng C
Trends Microbiol; 2021 Sep; 29(9):776-778. PubMed ID: 33483164
[TBL] [Abstract][Full Text] [Related]
33. Insights into the biogenesis, function, and regulation of ADP-ribosylation.
Cohen MS; Chang P
Nat Chem Biol; 2018 Feb; 14(3):236-243. PubMed ID: 29443986
[TBL] [Abstract][Full Text] [Related]
34. Detection of ADP-Ribosylating Bacterial Toxins.
Chen C; Barbieri JT
Methods Mol Biol; 2018; 1813():287-295. PubMed ID: 30097876
[TBL] [Abstract][Full Text] [Related]
35. Identifying Target RNAs of PARPs.
Bock FJ; Chang P
Methods Mol Biol; 2018; 1813():327-341. PubMed ID: 30097879
[TBL] [Abstract][Full Text] [Related]
36. Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones.
Brustel J; Muramoto T; Fumimoto K; Ellins J; Pears CJ; Lakin ND
Nat Commun; 2022 Jan; 13(1):185. PubMed ID: 35027540
[TBL] [Abstract][Full Text] [Related]
37. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.
Fehr AR; Singh SA; Kerr CM; Mukai S; Higashi H; Aikawa M
Genes Dev; 2020 Mar; 34(5-6):341-359. PubMed ID: 32029454
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis for the reversible ADP-ribosylation of guanosine bases.
Schuller M; Raggiaschi R; Mikolcevic P; Rack JGM; Ariza A; Zhang Y; Ledermann R; Tang C; Mikoc A; Ahel I
Mol Cell; 2023 Jul; 83(13):2303-2315.e6. PubMed ID: 37390817
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Determination of MAR Hydrolase Residue Specificity In Vitro by Tandem Mass Spectrometry.
McPherson RL; Ong SE; Leung AKL
Methods Mol Biol; 2018; 1813():271-283. PubMed ID: 30097875
[TBL] [Abstract][Full Text] [Related]
40. ADP-ribosyltransferases and poly ADP-ribosylation.
Liu C; Yu X
Curr Protein Pept Sci; 2015; 16(6):491-501. PubMed ID: 25938242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]